Aeterna Zentaris
AEZS
$2.75
Share price
-0.39%
Change (1 day)
-42.12%
Change (1 year)
Categories
Aeterna Zentaris (AEZS) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $20.25 M
According to Aeterna Zentaris's latest financial reports the company's total liabilities are $20.25 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aeterna Zentaris - Total liabilities on balance sheet (from 2001 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2021-12-31 | $27.11 M | 12.67% |
| 2020-12-31 | $24.06 M | 7.23% |
| 2019-12-31 | $22.44 M | -2.86% |
| 2018-12-31 | $23.1 M | -7.5% |
| 2017-12-31 | $24.97 M | -1.84% |
| 2016-12-31 | $25.44 M | -14.84% |
| 2015-12-31 | $29.88 M | -9.31% |
| 2014-12-31 | $32.95 M | -21.79% |
| 2013-12-31 | $42.13 M | -43.34% |
| 2012-12-31 | $74.36 M | -6.95% |
| 2011-12-31 | $79.91 M | 24.6% |
| 2010-12-31 | $64.13 M | -16.75% |
| 2009-12-31 | $77.03 M | -11.32% |
| 2008-12-31 | $86.86 M | 149.82% |
| 2007-12-31 | $34.77 M | -22.06% |
| 2006-12-31 | $44.61 M | -82.26% |
| 2005-12-31 | $0.25 B | 55.69% |
| 2004-12-31 | $0.16 B | 49.93% |
| 2003-12-31 | $0.10 B | -13.45% |
| 2002-12-31 | $0.12 B | 429.91% |
| 2001-12-31 | $23.48 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $60.09 B | 296,685.19% | 🇨🇭 Switzerland |
 Sanofi SNY | $55.23 B | 272,641.23% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $62.39 B | 308,023.46% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $75.45 M | 272.59% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.67 B | 8,155.36% | 🇺🇸 USA |